Projects funded by the NCN
The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease.
2019/33/B/NZ5/00609
Keywords:
leukotrienes atherosclerosis restenosis biomarkers cysteinyl leukotriene receptor antagonist
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 17 - announced on 2019-03-15
Amount awarded: 1 745 600 PLN
Project start date (Y-m-d): 2020-05-04
Project end date (Y-m-d): 2023-05-03
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.